Pericles Calias
2018
In 2018, Pericles Calias earned a total compensation of $351.3K as Former Chief Scientific Officer at Avalo Therapeutics.
Compensation breakdown
| Bonus | $47,868 |
|---|---|
| Option Awards | $184,270 |
| Salary | $119,167 |
| Total | $351,305 |
Calias received $184.3K in option awards, accounting for 52% of the total pay in 2018.
Calias also received $47.9K in bonus and $119.2K in salary.
Rankings
In 2018, Pericles Calias' compensation ranked 12,855th out of 14,244 executives tracked by ExecPay. In other words, Calias earned more than 9.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,855 out of 14,244 | 10th |
Division Manufacturing | 5,202 out of 5,765 | 10th |
Major group Chemicals And Allied Products | 1,959 out of 2,128 | 8th |
Industry group Drugs | 1,680 out of 1,817 | 8th |
Industry Pharmaceutical Preparations | 1,288 out of 1,391 | 7th |
Source: SEC filing on April 28, 2020.
Calias' colleagues
We found six more compensation records of executives who worked with Pericles Calias at Avalo Therapeutics in 2018.
2018
Peter Greenleaf
Avalo Therapeutics
Chief Executive Officer
2018
Mariam Morris
Avalo Therapeutics
Chief Financial Officer
2018
Joseph Miller
Avalo Therapeutics
Chief Financial Officer
2018
James Harrell
Avalo Therapeutics
Executive Vice President, Marketing and External Communications
2018
Robert Moscato
Avalo Therapeutics
Chief Operating Officer
2018
Simon Pedder
Avalo Therapeutics